Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) Stock Information | RedChip

Sonnet BioTherapeutics Holdings Inc. (NASDAQ: SONN) Listen to this Section


$0.66
-0.1530 ( -18.90% ) 742.6K

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

Market Data


Open


$0.66

Previous close


$0.81

Volume


742.6K

Market cap


$3.43M

Day range


$0.63 - $0.84

52 week range


$0.63 - $8.19

Insider Ownership Transactions

Total Amount Purchased: 50,000.00 | $ 32,875.00

Date Type Amount Purchased Purchaser
2023-10-27 Buy 34375.00 Mohan Pankaj
2023-10-27 Buy 15625.00 Rao Raghu

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 14, 2024
10-q Quarterly Reports 54 Aug 14, 2024
pre Proxies and info statements 5 Aug 09, 2024
8-k 8K-related 13 Aug 09, 2024
8-k 8K-related 17 Jul 24, 2024
8-k 8K-related 17 Jun 20, 2024
8-k 8K-related 47 Jun 14, 2024
8-k 8K-related 14 Jun 13, 2024
8-k 8K-related 14 May 22, 2024
8-k 8K-related 14 May 20, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.